Workforce education and development are key cornerstones in advancing and maturing the Cell & Gene Therapy sector. A skilled worker shortage can significantly impact and delay progress as well as the quality of output for any developer, thereby negatively impacting a patient's access to life-saving treatments. Several roundtable discussions were held at the International Society for Cell & Gene Therapy (ISCT) 2023 Annual Meeting to dive deeper into the current state of workforce development and solutions to address this bottleneck. One roundtable discussion was co-hosted by the Alliance for Regenerative Medicine (ARM) and ISCT, which focused on the gap analysis provided for the United States Cell & Gene Therapy (CGT) sector, highlighting the lack of skilled workers in manufacturing and quality control.

中文翻译：

---

填补空白：随着行业的进步，CGT 制造业的未来劳动力


劳动力教育和发展是细胞和基因治疗领域发展和成熟的关键基石。熟练工人的短缺可能会严重影响和延迟任何开发人员的进度和产出质量，从而对患者获得挽救生命的治疗产生负面影响。国际细胞与基因治疗学会 (ISCT) 2023 年年会举行了多次圆桌讨论，深入探讨劳动力发展的现状以及解决这一瓶颈的解决方案。再生医学联盟 (ARM) 和 ISCT 联合主办了一场圆桌讨论，重点讨论了为美国细胞与基因治疗 (CGT) 行业提供的差距分析，强调了制造和质量控制方面熟练工人的缺乏。